|
Sign In to gain access to subscriptions and/or personal tools.
|
Losartan may prevent the elevation of plasma glucose, corticosterone and catecholamine levels induced by chronic stress
Ya iz Üresin
Istanbul Faculty of Medicine, Department of Pharmacology and Clinical Pharmacology, Istanbul University, 34390 Capa, Istanbul, Turkey, yagiz{at}istanbul.edu.tr
Bahar Erbas
Istanbul Faculty of Medicine, Department of Pharmacology and Clinical Pharmacology, Istanbul University, 34390 Capa, Istanbul, Turkey
Mehmet Özek
Istanbul Faculty of Medicine, Department of Pharmacology and Clinical Pharmacology, Istanbul University, 34390 Capa, Istanbul, Turkey
Elif Özkök
Research Institute of Experimental Medicine, Department of Neuroscience, Istanbul University, 34390 Capa, Istanbul, Turkey
Ali Osman Gürol
Research Institute of Experimental Medicine, Department of Immunology, Istanbul University, 34390 Capa, Istanbul, Turkey
Introduction
Stress is a stimulus that activates the hypothalamic pituitary adrenal (HPA) axis and sympathetic nervous system (SNS). Increased activity of the SNS causes to increment or impairment in blood pressure, heart rate, body temperature and plasma glucose and adrenocorticotrophic hormone (ACTH) levels. Angiotensin II (Ang II), which is a product of the renin-angiotensin system (RAS), is an important factor affecting the activity of the SNS and responses to stress. We suggest that the blockade of Ang II may be worthwhile in the prevention and treatment of diabetes mellitus and cardiovascular diseases affected by stress. Therefore, we investigated the effects of immobilisation stress on blood glucose, norepinephrine (NE), epinephrine (E) and corticosterone levels and the effects of an Ang II receptor antagonist, losartan, on these parameters.
Materials and methods
The rats were kept in small cylindrical cages for 60 min/day for 10 consecutive days to perform chronic immobilisation stress. Losartan (10 mg/kg) was given daily by gavage to Losartan (L) and Losartan + Chronic Stress (L+CS) groups. Control (C) and Chronic Stress (CS) P groups received an equal volume of saline daily by gavage for 10 days. After the last stress regimen, blood samples were collected for plasma glucose, NE, E and corticosteroid measurements.
Results
Plasma glucose, NE, E and corticosterone levels in the CS Group increased significantly compared with the C group. In Group L+CS, the plasma glucose, NE, E and corticosterone levels decreased significantly vs. Group CS. In Group L there was no significant difference vs. Group C.
Conclusion
It can be speculated that chronic blockade of RAS may decrease the excess sympathetic responses to stress in cardiovascular diseases and prevent the likely development of Type II diabetes mellitus.
Key Words: losartan chronic stress glucose angiotensin II corticosterone norepinephrine epinephrine sympathetic nervous system
References
- Maier SF, Watkins LR Cytokines for psychologists: Implications for bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 1998;105:83-107.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- McCubbin JA, Kaufmann PG, Nemeroff CB Stress, neuropeptides and systemic disease. San Diego: Academic Press, 1991.
- Stanford SC, Salmon P. Stress:from synapse to syndrome. San Diego: Academic Press, 1993.
- Nonogaki K., Iguchi A. Stress, Acute Hyperglycemia, and Hyperlipidemia: Role of the autonomic nervous system and cytokines. Trends Endocrinol Metab 1997;8:192-7.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Xang G., Xi ZX,Wan Y.,Wang H., Bi G. Changes in circulating and tissue angiotensin II during acute and chronic stress. Biol Signals 1993;2:166-72.[Medline]
[Order article via Infotrieve]
- Saavedra JM Brain and pituitary angiotensin. Endocr Rev 1992;13:329-80.[Abstract/Free Full Text]
- Saavedra JM Emerging features of brain angiotensin receptors. Regul Pept 1999;85:31-45.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Aguilera G., Kiss A., Luo X. Increased expression of type 1 angiotensin II receptors in the hypothalamic paraventricular nucleus following stress and glucocorticoid administration. J Neuroendocrinol 1995;7:775-83.[Web of Science][Medline]
[Order article via Infotrieve]
- Castrén E., Saavedra JM Repeated stress increases the density of angiotensin II binding sites in the rat paraventricular nucleus and subfornical organ. Endocrinology 1988;122:370-2.[Abstract/Free Full Text]
- Yang G., Wan Y., Zhu Y. Angiotensin II - an important stress hormone. Biol Signals 1996;5:1-8.[Medline]
[Order article via Infotrieve]
- Wright JW, Hardling JW Regulatory role of brain angiotensins in the control of physiological and behavioral responses. Brain Res Rev 1992;17:227-62.[CrossRef][Medline]
[Order article via Infotrieve]
- Wright JW, Hardling JW Brain angiotensin receptor subtypes in the control of physiological and behavioral responses. Neurosci Biobehav Rev 1994;18:21-53.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hilgers KF, Veelken R., Rupprecht G. et al. Angiotensin II facilitates sympathetic transmission in rat hind limb circulation. Hypertension 1993;21:322-8.[Abstract/Free Full Text]
- Zimmerman JB, Robertson D., Jackson EKAngiotensin IInoradrenergic interactions in renovascular hypertensive rats. J Clin Invest 1987;80:443-57.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Zimmerman BG, Sybertz EJ,Wong PC Interaction between sympathetic and renin-angiotensin system. J Hypertens 1984; 2:581-7.[CrossRef][Medline]
[Order article via Infotrieve]
- Szabo B., Hedler L., Schurr C., Starke K. Peripheral presynaptic facilitatory effect of angiotensin II on noradrenaline release in anesthetized rabbits. J Cardiovasc Pharmacol 1990; 15:968-75.[Web of Science][Medline]
[Order article via Infotrieve]
- Zaman MA, Oparil S., Calhoun DA Drugs targeting the renin-angiotensin-aldosterone system. Nat Rev Drug Discov 2002;1:621-36.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Sweerts B., Jarrott B., Lawrence AJ Expression of preprogalanin mRNA following acute and chronic restraint stress in brains of normotensive and hypertensive rats. Mol Brain Res 1999;69:113-23.[Medline]
[Order article via Infotrieve]
- Krstulovic AM, Dziedzic SW, Dziedzic LB, Dirico DE Plasma catecholamines in hypertension and pheochromocytoma determined using ion-pair reversed-chromatography with amperometric detection. J Chromatogr 1981;217:523-37.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Zenker N., Bernstein DE The estimation of small amounts of corticosterone in rat plasma. J Biol Chem 1958;231:695-701.[Free Full Text]
- Glick D., von Redlich D., Levine S. Fluorometric determination of corticosterone and cortisol in 0.02-0.05 milliliters of plasma or submilligram samples of adrenal tissue. Endocrinology 1964;74:653-5.[Web of Science][Medline]
[Order article via Infotrieve]
- Kemmer FW, Bisping R., Steingruber HJ et al. Psychological stress and metabolic control in patients with type I diabetes mellitus.NEnglJMed 1986;314:1078-84.[Abstract]
- Raikkonen K., Keltikangas-Jarvinen L., Adlercreutz H., HautanenA. Psychological stress and the insulin resistance syndrome. Metabolism 1996;45:1533-8.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Van der Does FE, De Neeling JN, Snoek FJ et al. Symptoms and well-being in relation to glycemic control in type II diabetes. Diabetes Care 1996;19:204-10.[Abstract]
- Kubo T., Numakura H., Endo S., Hagiwara Y., Fukumori R. Angiotensin receptor blockade in the anterior hypothalamic area inhibits stress-induced pressor responses in rats. Brain Res Bull 2001;56:569-74.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Saiki Y., Watanabe T., Tan N., Matsuzaki M., Nakamura S. Role of central ANG-II receptors in stress-induced cardiovascular and hyperthermic responses in rats. Am J Physiol 1997;272 R26-R33.[Web of Science][Medline]
[Order article via Infotrieve]
- Armando I., Carranza A., Nishimura Y. et al. Peripheral administration of an angiotensin II AT1 receptor antagonist decreases the hypothalamic-pituitary-adrenal response to isolation stress.Endocrinology 2001;142:3880-9.[Abstract/Free Full Text]
- Yang G., Xi Z., Wan Y., Wang H., Bi G. Changes in circulating and tissue angiotensin II during acute and chronic stress. Biological Signals 1993;2:166-72.[Medline]
[Order article via Infotrieve]
- Golin RMA, Gotoh E., Said SI, Ganong WF Pharmacological evidence that the sympathetic nervous system mediates the increase in renin secretion produced by immobilization and head tilt in rats. Neuropharmacology 1988;27:1209-13.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Nakamaru M., Jackson EK, Inagami T. β-adrenoceptor-mediated release of angiotensin II from mesenteric arteries. Am J Physiol 1986;250:H144-H148.[Web of Science][Medline]
[Order article via Infotrieve]
- Watanabe T., Fujioka T., Hashimoto M., Nakamura S. Stress and brain angiotensin II receptors. Crit Rev Neurobiol 1998; 12:305-17.[Web of Science][Medline]
[Order article via Infotrieve]
- Green PG, Janig W., Levine JD Negative feedback neuroendocrine control of inflammatory response in the rat is dependent on the sympathetic postganglionic neuron. J Neurosci 1997;17:3234-8.[Abstract/Free Full Text]
- Black PH Stress and the inflammatory response:A review of neurogenic inflammation. Brain Behav Immun 2002;16: 622-53.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Moan A., Hoieggen A., Nordby G., Eide IK, Kjeidsen SE Effects of losartan on insulin sensitivity in severe hypertension: connections through sympathetic nervous system activity? J Hum Hypertens 1995;9:S45-S50.[Web of Science][Medline]
[Order article via Infotrieve]
- Heinig RE What should the role of ACE inhibitors be in the treatment of diabetes? Lessons from HOPE and MICRO-HOPE. Diabetes Obes Metab 2002;4(suppl 1):S19-S25.[Web of Science][Medline]
[Order article via Infotrieve]
- Dahlof B., Devereux RB, Kjeldsen SE et al. The LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet 2002;359: 995-1003.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hansson L., Lindholm LH, Niskanen L. et al. Effects of angiotensin-converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertens H ion: the Captopril Prevention Project (CAPPP) randomized trial. Lancet 1999;353:611-16.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Murali B., Goyal RK Improvement in insulin sensitivity by losartan in non-insulin-dependent diabetic (NIDDM) rats. Pharmacol Res 2001;44:385-9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
Journal of Renin-Angiotensin-Aldosterone System, Vol. 5, No. 2,
93-96 (2004)
DOI: 10.3317/jraas.2004.017

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Muller, N. Schweitzer, O. Johren, P. Dominiak, and W. Raasch
Angiotensin II stimulates the reactivity of the pituitary-adrenal axis in leptin-resistant Zucker rats, thereby influencing the glucose utilization
Am J Physiol Endocrinol Metab,
September 1, 2007;
293(3):
E802 - E810.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|